Brain stimulation for schizophrenia
Part of Mental health clinical trials.
This study tests a brain stimulation treatment (neuromodulation) to improve brain connectivity in people with schizophrenia. It aims to see if this approach can help with symptoms and cognitive function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have a diagnosis of a schizophrenia-spectrum disorder.
- You must be able to give written informed consent.
- You must not have a history of seizures.
- You must not have an unstable medical condition affecting the brain, such as a recent stroke, head injury, brain infection, or tumor.
- You cannot take more than 400 mg of clozapine per day unless you are also taking anti-seizure medication.
- You must not have significant alcohol or drug use in the past month (except nicotine or marijuana).
- You must not have a history of blood clots or conditions that increase blood clot risk.
- If you are a woman able to have children, you must not be pregnant.
- You must be able to undergo MRI scans (no metal implants, no claustrophobia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non-invasive brain stimulation technique called TMS can improve brain connections in people with schizophrenia. It involves two types of MRI scans and several TMS sessions to see if it can help with thinking and symptoms.
This study tests if brain stimulation can improve how different brain regions communicate in people with schizophrenia. It may help improve thinking and daily function.
This trial tests a type of brain stimulation called TMS to see if it can change brain connections that may be linked to symptoms. It might help people with schizophrenia or schizoaffective disorder who are stable on their current medications.
This study compares two types of mild brain stimulation—tACS and tDCS—to see if they can help reduce symptoms of schizophrenia. It is for people who have had moderate to severe symptoms for at least two years and are on stable medications.
This trial tests whether a non-invasive brain stimulation technique (rTMS) can improve thinking and memory in people with psychosis. It involves MRI scans and several study visits at McLean Hospital.
This study tests a type of brain stimulation called high-definition transcranial alternating current stimulation (hi-tACS) to see if it can improve thinking and memory in people with schizophrenia. If you are a right-handed adult with stable schizophrenia, you may be able to join.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.